We have investigated the mechanisms by which alleles at the mouse Fv-1 locus restrict replication of murine leukemia viruses. Inhibition of productive infection is closely paralleled by reduced accumulation of integrated proviral DNA as well as by reduced levels of linear viral DNA in a cytoplasmic fraction. Nevertheless, viral DNA is present at nearly normal levels in a nuclear fraction, and total amounts of viral DNA are only mildly affected in restrictive infections, suggesting a block in integration to account for reduced levels of proviral Studies of Fv-1 restriction in cell culture demonstrated that restriction operates after entry of virus into the cell but before or during integration of viral DNA into the host cell genome (7, 27, 29-31, 48, 51). Restriction is not absolute; usually, between 10-and 1,000-fold fewer cells are productively infected in a restrictive host than in a permissive host. The stage of the viral replication cycle that is inhibited is * Corresponding author.
DNA is present at nearly normal levels in a nuclear fraction, and total amounts of viral DNA are only mildly affected in restrictive infections, suggesting a block in integration to account for reduced levels of proviral DNA. However, integrase (IN)-dependent trimming of 3' ends of viral DNA occurs normally in vivo during restrictive infections, demonstrating that not all IN-mediated events are prevented in vivo. Furthermore, viral integration complexes present in nuclear extracts of infected restrictive cells are fully competent to integrate their DNA into a heterologous target in vitro. Thus, the Fv-1-dependent activity that restricts integration in vivo may be lost in vitro; alternatively, Fv-1 restriction may prevent a step required for integration in vivo that is bypassed in vitro.
Fv-1 is a normal mouse gene, alleles of which encode the ability to inhibit the replication of certain classes of mouse retroviruses, the murine leukemia viruses (MLVs) (for reviews, see references 28 and 50). The two common alleles of Fv-1, Fv-l' and Fv-1b, are so called because of their presence in the prototypical mouse strains NIH and BALB, respectively. MLV strains are grouped according to their susceptibility to Fv-1 alleles: Fv-l' inhibits replication of B-tropic MLVs, and Fv-1b inhibits replication of N-tropic MLVs. This inhibition, known as Fv-1 restriction, is dominant; Fv-1n/b heterozygotes inhibit replication of both N-and B-tropic MLV replication. Virtually all inbred strains of laboratory mice carry one of these two Fv-1 alleles, but wild mice, Mus species other than M. musculus, and cell lines derived from them may be permissive for both classes of MLV and hence are called Fv-1-'- (28, 35) .
The determinants of viral tropism lie within the gagencoded capsid (CA) protein (formerly called p309ag), and a swap of two adjacent amino acids in CA between N and B sequences can completely reverse viral tropism (1, 11) . Nearly all isolates of ecotropic MLVs from laboratory strains of mice are either N or B tropic (28) , although some isolates from wild mice or other species of mice are insensitive to both alleles of Fv-1 (37, 49) . In addition, many common laboratory strains of MLV, such as Moloney MLV (MoMLV), have acquired insensitivity to Fv-1 restriction, presumably through mutation during multiple passages in culture (14, 24) . Such MLV strains that are not restricted by either allele of Fv-1 are termed NB tropic and appear to be missing determinants for restriction, since sensitivity to restriction is dominant (32, 44) .
Studies of Fv-1 restriction in cell culture demonstrated that restriction operates after entry of virus into the cell but before or during integration of viral DNA into the host cell genome (7, 27, 29-31, 48, 51) . Restriction is not absolute; usually, between 10-and 1,000-fold fewer cells are productively infected in a restrictive host than in a permissive host. The stage of the viral replication cycle that is inhibited is * Corresponding author.
somewhat variable and apparently dependent on the particular host-virus combination. In some cases, restriction can be accounted for by an inhibition of viral DNA synthesis (51) . In most cases, however, normal or nearly normal levels of linear viral DNA are synthesized during infection of restrictive cells, yet the acquisition of integrated proviruses (usually monitored by virus production from the recently infected cells) is severely decreased (7, 30, 31, 51) . Transfection experiments also show that virus production from integrated genomes is not inhibited in restrictive hosts (9, 25) .
Thus, Fv-1 restriction provides an intriguing example of host cell participation in the early stages of the retroviral life cycle. Earlier studies also found that, while linear viral DNA appears in normal amounts, formation of circular viral DNA is inhibited in restrictive hosts (7, 30, 31, 51) . At the time, it was generally believed that circular viral DNA (particularly the two-long-terminal-repeat [LTR] circle) was the precursor to integrated DNA and therefore that Fv-1 restriction of integration proceeded by inhibition of precursor circle formation. It is now clear that linear viral DNA, not circular DNA, is the normal precursor to integrated DNA (4, 10, 15, 20, 33, 39) ; thus, decreased circular DNA formation is more likely a reflection of the same inhibitory action that prevents integration in restrictive cells.
The recent development of in vitro assays for retroviral integration (3-5, 10, 19, 20, 33) provides an opportunity to learn more about the contribution of the Fv-1 gene product (the identity of which remains unknown) to the control of MLV replication. Intriguingly, the CA protein has been found to remain associated after infection with MLV DNAcontaining integration complexes (2) . We report here our efforts to duplicate Fv-1-mediated inhibition of MLV integration in a cell-free system by using extracts (3) . For this purpose, we generated N-and B-tropic viruses carrying the supF bacterial amber suppressor tRNA gene (3) in two ways (see Fig.  1 ): (i) insertion of the supF gene into the N-and B-tropic MLV LTRs and (ii) conversion of MoMLV-SupF from NB-tropic to N-and B-tropic versions by changing gag sequences. To construct pN-SupF and pB-SupF, the viral HindIII fragments from pN20-7 and pB16-5 were first cloned into the HindIII site of a PstI site-deleted derivative of the vector pSP65 (Promega). A supF-containing PvuII fragment of plasmid pVSU-II (38) , which contains the supF gene flanked by both EcoRI and PvuII sites, was then cloned into the viral LTRs at the unique PstI sites which had been made blunt with T4 polymerase; the resulting viruses retained their original tropism (see Fig. 1 ). Plasmids pN-MoF and pB-MoF were constructed by site-directed mutagenesis of the parental plasmid pMoMLV-SupF (3, 40) , changing the codons at positions 109 and 110 of CA in gag (Gln and Ala) to Gln and Arg (pN-MoF) or Thr and Glu (pB-MoF), which are the tropism-determining amino acids in naturally occurring Nand B-tropic viruses (11); these point mutations did not convert the NB-tropic parent virus to N or B tropism (see Fig. 1 ). Plasmids pN-ASMF and pB-ASMF were constructed by replacing the AatII-to-SalI fragment in pMoMLV-SupF with the analogous fragments from pN20-7 and pB16-5, respectively; these swaps were sufficient to convert the NB-tropic parent to N or B tropism (see Fig. 1 Integration reactions were performed essentially as described elsewhere (3, 4, 42) by using 500 ng of 4X174 DNA as an integration target for 50 pul of integration extract. Nucleic acids were prepared from extracts or integration reactions as described elsewhere (3) . DNAs were analyzed either with or without restriction enzyme digestion by electrophoresis in an 0.7% agarose gel, blotting to a Hybond-N nylon membrane (Amersham), UV cross-linking, and hybridization with a nick-translated probe. The probe used was either a mixture of AKV virus plasmid clones (either pN20-7 and pB16-5 or pWN41, pWB5, and pGN104) or of MoMLV-derived plasmid clones (pN-ASMF and pB-ASMF) or a supF PvuII fragment from plasmid pVSU-II. Tests for processing of the termini of viral DNA were performed as described in the legend to Fig. 6 and in reference 4.
Virion RNAs were analyzed by pelleting 450 pul of virus suspension for 5 min. at 30 lb/in2 in a Beckman Airfuge. The supernatant was removed by aspiration, and the pellet was resuspended in 100 pul of 10 mM Tris (pH 7.4)-10 mM EDTA-200 mM NaCl-0.5% sodium dodecyl sulfate and then extracted twice with phenol-chloroform and twice with ether. The sample was then heated to 65°C for 2 min and mixed with 100 ,ul of 20x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate). This mixture was subjected to serial fivefold dilutions in lOx SSC, and the dilutions were then blotted onto a Hybond-N nylon membrane by using a dot blot apparatus; the blot was then UV cross-linked and hybridized as described above for DNA analysis.
RESULTS
Accumulation of viral DNA in permissive and restrictive infections. Earlier work showed that, in some host-virus combinations, Fv-1 restriction could be accounted for by inhibition of viral DNA synthesis (51) . In other host-virus combinations, however, no defect in accumulation of linear viral DNA synthesis was seen, but formation of circular DNA and integration were inhibited (7, 30, 31, 51) . We wanted to address specifically, using an in vitro integration assay, the nature of the integration block in situations where linear DNA synthesis is normal in restrictive infections. Therefore, we analyzed the accumulation of viral DNA after infection of permissive and restrictive host cell lines by the viruses depicted in Fig. 1 and described in Materials and Methods. Since our intent was to test integration in vitro of DNAs synthesized in vivo, we fractionated newly infected cells into cytoplasmic and nuclear extracts of the sort that can serve as the source of integration machinery in unrestricted MoMLV infections (3) . The appearance of viral DNA in these fractions was then studied.
We observed a novel effect of Fv-1 on the accumulation of viral DNA: the appearance of linear DNA in the cytoplasmic fraction, but not in the nuclear fraction, was inhibited during infection of restrictive cells (Fig. 2) . This effect is shown for three different viruses infecting NIH 3T3 and BALB/3T3 cell lines ( Fig. 2A ) and for two additional viruses infecting NIH 3T3, BALB/3T3, and SC-1 cell lines (Fig. 2B) ; it was also observed for the two AKV/MoMLV chimeric viruses (see Fig. 6 ). Importantly, the degree of effect on cytoplasmic viral DNA correlated well with the degree of restriction of virus production. For example, in the experiment whose results are shown in Fig. 2A , roughly 20-fold differences were seen in both virus production and cytoplasmic DNA during infection of permissive and restrictive hosts; the overexposed panels show that the effect on cytoplasmic DNA was greater than 10-fold. Linear DNA in the nuclear fraction, on the other hand, was decreased only slightly or not at all (Fig.  2) . Circular DNA in the nuclear fraction was usually less abundant in restrictive than in permissive hosts ( Fig. 2A (Fig. 3) . The absence of DNA in both cytoplasmic and nuclear fractions of restrictive host cells at the earliest time point (4 h) demonstrates that the decrease in cytoplasmic DNA is not due to a more rapid migration of DNA to the nuclear fraction. The time course experiment also shows that the effect of Fv-1 on total DNA, measured by summation of the cytoplasmic and nuclear DNAs, depends on the time after infection. At the earliest time point, when no nuclear DNA is seen, total DNA is severely decreased in restrictive infections. Eventually, however, at later time points the level of total DNA in restrictive cells is within two-to fivefold of that in permissive cells. A particularly clear example is seen in Fig. 2A . A comparison of GN104 infection of NIH 3T3 and BALB/3T3 cells shows that the nuclear DNA levels in the two infections are roughly equal to the cytoplasmic DNA level in the permissive infection; thus, total DNA is decreased by about 2-fold in the restrictive case, even though restriction (as measured by virus production) was roughly 25-fold.
Restriction of integration in vivo. To confirm that the accumulation of integrated proviruses is inhibited in restrictive infections, we took advantage of the foreign insert (the supF gene) present in our N-SupF and B-SupF viruses. Hybridization to high-molecular-weight genomic DNA with the supF insert as a probe avoids the problem of background hybridization to endogenous MLV sequences that compromised previous measurements of integration in Fv-1 restriction experiments (29, 48) . The efficiency of integration in vivo was compared for permissive and restrictive infections by first preparing high-molecular-weight DNA from the nuclei of newly infected cells by Hirt fractionation (23). This DNA was then cleaved with a restriction enzyme that releases the supF insert from integrated proviruses and hybridized to a supF probe after electrophoresis and blotting (Fig. 4) . The degree of Fv-1 restriction of productive infection was well correlated with impaired accumulation of integrated proviruses, since the expected 215-bp supF fragment was released from the Hirt pellet DNA after infection of permissive but not restrictive hosts (Fig. 4C) . Hybridization of uncut DNAs with an MLV probe showed that the Hirt pellet fractions were not significantly contaminated with differential amounts of unintegrated DNA and that they contained relatively equal amounts of genomic DNA (Fig.  4A) .
Integration in vitro. The experiments described above show that levels of linear viral DNA in the nuclear fractions of infected restrictive cells are nearly normal but that integration is inhibited. Therefore, we compared the abilities of nuclear extracts from permissive and restrictive infections to integrate their DNA in vitro into an exogenously provided target. In the in vitro integration assay, DNA-containing nucleoprotein complexes present in cell extracts insert linear viral DNA into an added circular DNA target (+OX174 DNA).
Upon restriction enzyme digestion, the integration products give rise to a large new cleavage product, which is visualized by hybridization with an MLV probe after electrophoresis and blotting (4, 42) . We observed that viral complexes in nuclear extracts from restrictive infections were as competent to integrate their DNA as those from permissive infections (Fig. 5) , as indicated by the generation of a 13.2-kb product (HindIII-SalI digest) or a 9.2-kb product (BamHI digest). The mild variability in the final amount of product reflects the initial amount of viral DNA (as indicated by the 1.1-or 3.0-kb band in the HindIII-SalI or BamHI digest, respectively); thus, the specific activities were roughly equivalent for complexes present Fig. 2A) , were tested for integration activity in vitro. Extracts were incubated with 4X174 DNA as an integration target and then analyzed by digestion with HindIIl and SalI (A) or with BamHI (B) followed by Southern blotting and hybridization with an AKV MLV probe. Integration of MLV DNA into 4X174 DNA gives unique 13.2-kb (top) or 9.2-kb (bottom) digestion products (as diagrammed on the right), which are seen to be approximately equal for extracts from infections of permissive and restrictive cells. The relative amounts of viral DNA in the extracts are indicated by internal digestion products of 1.1 kb (top) or 3.0 kb (bottom) in size, which are generated from both unintegrated and integrated DNAs. The bands at approximately 7.8 and 7.2 kb in the HindIII-SalI digest (top) correspond in size to either one-or two-LTR circles (expected in small amounts in these nuclear extracts [ Fig. 2A]) or intramolecular recombinants (autointegrants [17, 36, 47] ); the absence of a significant two-LTR circle digestion product in the BamHI digest (expected size = 3.8 kb) suggests that the observed signal results primarily from autointegrants. removal of two bases from the 3' ends of linear DNA (4, 10, 20, 33, 45) . The exact 3' terminus of the U3 end of viral DNA was determined by restriction enzyme cleavage at a point close to the end (Fig. 6B) followed by denaturing polyacrylamide gel electrophoresis and hybridization with an LTR probe equivalent to the plus strand of viral DNA (4, 20) . We found that the U3 end of linear DNA in the nuclear fraction of infected restrictive cells had a normally processed 3' end, which was recessed two bases from the 5' end (332-base fragment [ Fig. 6C]) . Note that this blot also documents the integrity of the 5' end of U5 (398-base fragment). Other experiments indicated that the 3' end was also properly denatured, and electrophoresed on a 6% polyacrylamide-7 M urea gel (4) . The gel was electroblotted, and the blot was hybridized with a minus-strand-specific M13 clone containing an XbaI-XbaI circle junction MoMLV LTR fragment as described previously (4) . Also run in the same gel were samples of pMoMLV-SupF plasmid DNA that had been digested with PvuII and SacI (lanes DNA) and products of sequencing reactions using the M13 DNA described above as a template and a primer that has a 5' end equivalent to that formed by the PvuII digestion (primer D in reference 4). The blot shows that in all nuclear extracts, the U3 3' ends have been properly processed to the 332-base -2 position; the arrow indicating the 332-base fragment points to the A nucleotide in the sequence 5 What accounts for the differential effects on cytoplasmic and nuclear DNAs, and how do these effects relate to the restriction mechanism? There are several possible explanations, two of which will be considered here. Perhaps the simplest explanation is that viral DNA synthesis is slowed, but not stopped, upon entry into a restrictive cell. If migration of the viral nucleoprotein complex to the nucleus were to occur at a normal rate, independent of the completion of DNA synthesis, then the slower DNA synthesis would appear to occur primarily in the later compartment, the nucleus. In this model, the linear DNA eventually appearing in the nuclear fraction would nevertheless be blocked from integrating by Fv-J. A potentially related observation was made with quiescent cells infected with spleen necrosis virus, where, upon release from quiescence, DNA appeared in the nuclear fraction without a prior appearance in the cytoplasm (18) .
An alternative, and perhaps extreme, model posits that the DNA detected in the nuclear fraction does not normally participate in integration and that the DNA in the cytoplasmic fraction is instead the relevant precursor to integrated proviruses. Although this model does not account for the reduced amount of cytoplasmic DNA, it would explain the correlation of cytoplasmic DNA levels, rather than nuclear DNA levels, with integration and virus production. Thus Alternatively, Fv-1 may not inhibit integration activity directly in vivo. It is possible that Fv-1 blocks a step that is required for integration in vivo but not in vitro. For instance, the integration machinery in vivo might require transit to particular locations within the nucleus in order to come into contact with chromosomal DNA, and this proper intranuclear localization could be prevented in restrictive infections. Possibly relevant in this regard is the decreased level of circular viral DNA in restrictive infections. Some circular DNAs are in fact intramolecular recombinants, or "autointegrants" (47) , but a significant fraction probably represents products of host cell activities (such as ligation and homologous recombination) that are independent of viral integration activities (12, 13, 43, 46, 47) . If these host activities were located in the same intranuclear compartment as chromosomal target DNA, mislocalization would prevent both integration and host-mediated circular DNA formation. Indeed, fractionation studies imply differential localization or association of circular and linear DNAs, since release of circular DNAs from the nuclear fraction requires more drastic disruption than does release of linear DNA (unpublished observations).
It is also possible that the linear DNA seen in our nuclear fraction in restrictive infections is not actually in the nucleus but is instead attached to the outside of the nuclear membrane or perhaps associated with the cytoskeleton. The inability to migrate into the nucleus would therefore prevent both integration and circle formation. Biochemical fractionation has previously been misleading about subcellular localization (16, 22) . In addition, large cytoplasmic structures, such as the actin-based cytoskeleton, most likely partition with the nuclear fraction (6, 34) . Localization of MLV DNA by in situ hybridization (41) rather than by biochemical fractionation would be helpful in resolving whether viral DNA migrates to the nucleus in restrictive infections.
Infection of permissive cells with MLV (and other retroviruses) in the presence of either aphidicolin (a cellular DNA synthesis inhibitor) or cycloheximide (a protein synthesis inhibitor) results in a phenotype similar to that of Fv-1 restriction-namely, normal levels of linear viral DNA are synthesized, but formation of circular DNA and integration are inhibited (8, 21, 26, 52 ). Recent experiments demonstrate that the aphidicolin effect (and by analogy probably also the cycloheximide effect) can be explained by a requirement for the cell to proceed through mitosis in order for integration of MLV DNA to take place (44a). This requirement might reflect poor nuclear localization of MLV DNA in the absence of nuclear envelope breakdown during mitosis. We have found that, upon fractionation of cells infected with MLV in the presence of aphidicolin or cycloheximide, linear viral DNA appears normally in the nuclear fraction (unpublished observations); however, the biochemical fractionation may be misleading. Furthermore, integration of DNA synthesized in such drug-treated cells occurs normally in vitro when extracts prepared from these cells are used, even though circle formation and integration in vivo are prevented (unpublished observations); these observations mirror those of Fv-1 restriction and provide another example in which integration may be prevented in vivo without inhibition of integration activity per se.
Our observations limit the number of potential mechanisms by which Fv-1 can prevent integration in vivo. The isolation of fully functional integration complexes from infected restrictive cells (Fig. 5) shows that the integration complexes are not irreversibly or drastically damaged in the cell. Thus, mechanisms that involve large-scale proteolytic cleavage or disassembly of the components of the integration complex can be disregarded. Potential mechanisms are further limited by the important observation that the 3'-end processing reaction occurs normally during infection of restrictive cells (Fig. 6) . Thus, the Fv-1-dependent host cell apparatus cannot simply inhibit all activities of the IN protein in vivo. Instead, IN-mediated 3' end processing occurs normally, yet integration is prevented. It could be argued that the early stage at which this processing occurs (4, 45) precedes the action of Fv-1 against IN activity at later stages. However, the effect on cytoplasmic DNA suggests that the Fv-1-dependent action occurs very early, before complete synthesis of full-length DNA. Viable models for the mechanism of Fv-1 restriction will need to incorporate the present observations.
